Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 11,430 shares at $98.42 ($1.1M) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.42 | 3,872 | $381K | 33.7% |
| 2 | $99.29 | 7,434 | $738K | 65.2% |
| 3 | $99.97 | 124 | $12K | 1.1% |
| Total | $99.00 avg | 11,430 | $1.1M | 100% |
| Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $721K | — | Filing → |